The CEO told Reuters that the Mead Johnson acquisition had already benefited Reckitt, although it has only just reversed several quarters of... ...http://www.business-standard.com/article/reuters/reckitt-ceo-stands-by-mead-johnson-deal-despite-pfizer-option-118031000297_1.html
(Reuters) - Pfizer Inc's Xeljanz should be approved to treat patients with moderate to severe ulcerative colitis, a chronic bowel disease, a U.S.... ...http://feeds.reuters.com/~r/reuters/INhealth/~3/JmwnG5PAXHE/fda-panel-backs-pfizers-xeljanz-as-bowel-disease-treatment-idINKCN1GK2TW
A recent report has suggested that future patent expires in the cardiac and anti-diabetes space would form a good opportunity for smaller firms,... ...http://www.rediff.com/money/report/prices-of--key-diabetes-cancer-drugs-may-drop-by-25/20180308.htm
(Reuters) - Use of Xtandi in early stage prostate cancer on top of standard hormone therapy reduced the risk of disease spreading or death by 71... ...http://feeds.reuters.com/~r/reuters/INhealth/~3/mObbriZUCmE/pfizers-xtandi-delays-prostate-cancer-spread-in-early-stage-disease-idINKBN1FP2RX
to have submitted non-binding bids for Pfizer Inc’s consumer business after rival candidates walked away, according to people familiar with... ...http://www.business-standard.com/article/international/glaxosmithkline-reckitt-benckiser-in-final-lap-for-pfizer-inc-s-unit-118020500038_1.html
Pfizer is the world's largest...
Viagra is the brand name for the...